Jeff Yass’s Insys Therapeutics, Inc. INSY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q2 | – | Sell |
-21,561
| Closed | -$100K | – | 11222 |
|
|
2019
Q1 | $100K | Sell |
21,561
-14,786
| -41% | -$70K | ﹤0.01% | 8250 |
|
|
2018
Q4 | $127K | Buy |
+36,347
| New | +$253K | ﹤0.01% | 8093 |
|
|
2018
Q3 | – | Sell |
-59,757
| Closed | -$477K | – | 10762 |
|
|
2018
Q2 | $433K | Sell |
59,757
-42,712
| -42% | -$298K | ﹤0.01% | 7088 |
|
|
2018
Q1 | $619K | Sell |
102,469
-17,139
| -14% | -$142K | ﹤0.01% | 6209 |
|
|
2017
Q4 | $1.15M | Buy |
+119,608
| New | +$783K | ﹤0.01% | 4947 |
|
|
2017
Q3 | – | Sell |
-28,112
| Closed | -$290K | – | 10056 |
|
|
2017
Q2 | $356K | Buy |
+28,112
| New | +$333K | ﹤0.01% | 7264 |
|
|
2017
Q1 | – | Sell |
-84,523
| Closed | -$901K | – | 10538 |
|
|
2016
Q4 | $778K | Buy |
+84,523
| New | +$955K | ﹤0.01% | 6049 |
|
|
2016
Q3 | – | Sell |
-89,427
| Closed | -$1.36M | – | 9377 |
|
|
2016
Q2 | $1.16M | Buy |
89,427
+57,730
| +182% | +$841K | ﹤0.01% | 4564 |
|
|
2016
Q1 | $507K | Buy |
+31,697
| New | +$602K | ﹤0.01% | 6376 |
|
|
2015
Q4 | – | Sell |
-65,637
| Closed | -$1.82M | – | 10271 |
|
|
2015
Q3 | $1.87M | Buy |
65,637
+55,463
| +545% | +$2.04M | ﹤0.01% | 4406 |
|
|
2015
Q2 | $365K | Buy |
+10,174
| New | +$317K | ﹤0.01% | 8211 |
|
|
2014
Q4 | – | Sell |
-30,086
| Closed | -$595K | – | 10330 |
|
|
2014
Q3 | $583K | Buy |
30,086
+16,200
| +117% | +$254K | ﹤0.01% | 6938 |
|
|
2014
Q2 | $217K | Buy |
+13,886
| New | +$224K | ﹤0.01% | 8931 |
|
Other funds holding INSY
WS
Jeff Yass's INSY Position: Q2 2019 in Review
Jeff Yass sold out of Insys Therapeutics, Inc. (INSY) in Q2 2019, closing a stake of 21,561 shares — an estimated $100K sold.
Jeff Yass first reported a position in INSY in Q2 2014 and held it in 13 quarters. The position peaked at $1.87M in Q3 2015. 16 funds tracked by Wall St. Rank hold INSY as of Q2 2019.
- Jeff Yass reported no remaining Insys Therapeutics, Inc. position as of Q2 2019 after selling out during the quarter.
- Jeff Yass sold 21,561 Insys Therapeutics, Inc. shares in Q2 2019, an estimated $100K.
- Jeff Yass first reported a position in Insys Therapeutics, Inc. in Q2 2014 and held it in 13 quarters.
- Jeff Yass's Insys Therapeutics, Inc. position peaked at $1.87M in Q3 2015.
- 16 funds tracked by Wall St. Rank held Insys Therapeutics, Inc. as of Q2 2019.
Based on Susquehanna International Group's 13F filing for Q2 2019, filed 14 Aug 2019.